HIV-1 Coreceptor Use in Primary Target Cells
Author Information
Author(s): Loftin Lamorris, Kienzle Martha, Yi Yanjie, Collman Ronald G
Primary Institution: University of Pennsylvania School of Medicine
Hypothesis
How does HIV-1 coreceptor use in primary target cells affect viral entry and treatment strategies?
Conclusion
The study highlights the complexity of HIV-1 coreceptor use in primary cells and its implications for treatment with CCR5 antagonists.
Supporting Evidence
- HIV-1 coreceptor use is critical for understanding viral transmission and disease progression.
- R5X4 variants are the first CXCR4-using strains to emerge during infection.
- CCR5 antagonists may not effectively block R5X4 replication due to alternative coreceptor use.
Takeaway
HIV-1 can use different doorways to enter cells, and understanding which doorways it uses helps in creating better treatments.
Methodology
The study reviews existing literature and analyzes coreceptor use by HIV-1 in primary cells versus indicator cell lines.
Potential Biases
Potential bias in the interpretation of coreceptor use based on the limitations of existing predictive algorithms.
Limitations
The study relies on existing data and may not account for all variables affecting coreceptor use in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website